"Big Clinical Data" Analysis of Intravenous to Oral Conversions of Non-Antimicrobials.
Advantages of early intravenous (IV) to oral (PO) switches of antimicrobials are well known. Yet, little data have been published on reasonable IV-to-PO switches of other drug classes, although interventions to promote early IV-to-PO conversions may further increase patient safety and decrease costs. We therefore analyzed IV-to-PO switches of non-antimicrobials.